Background Cardiopulmonary exercise testing (CPET) is essential for assessing patients with hypertrophic cardiomyopathy (HCM) ...

Vascular endothelial growth factor inhibitors (VEGFIs) have transformed treatment paradigms for several malignancies. By ...

The identification and management of comorbidities are central to the care of patients with atrial fibrillation (AF). The ...

Background Apical hypertrophic cardiomyopathy (HCM) is a rare variant of HCM, often considered to have a benign prognosis. This study aimed to compare the clinical characteristics and genetic ...

Background Despite sub-optimal long-term results DC electrical cardioversion (DCCV) remains a main stay in atrial fibrillation (AF) management. In selected patients long-term success at 6 weeks is ...

Great Ormond Street Hospital for Children and UCL Institute of Child Health, London, UK Dr Alison Hislop, UCL Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK; a.hislop{at}ich.ucl.ac ...

BHF Health Promotion Research Group, Division of Public Health and Primary Health Care, University of Oxford, UK Dr M O’Flaherty, Division of Public Health, Whelan Building, Quadrangle, University of ...

Background Despite simpler regimens than vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF), adherence (taking drugs as prescribed) and persistence (continuation of drugs) ...

Around 40% of all patients undergoing angiography are found to have normal coronary arteries or non-obstructive coronary artery disease (NOCAD). Despite the high prevalence, this is a group who rarely ...

Arrhythmia Center, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China Dr S Zhang, Arrhythmia Center, Cardiovascular Institute and Fuwai Hospital, Chinese ...

Department of Cardiology, University Hospital of North Staffordshire, Stoke-on-Trent, UK Background: The transradial approach for percutaneous coronary procedures has the advantage of reduced access ...

Background Pulmonary hypertension (PHT) lacks community prevalence and outcome data. Objective To characterise minimum ‘indicative’ prevalences and mortality data for all forms of PHT in a selected ...